
Ten-Year-Old Drug Candidates Reveal the Difficulty of Making Metabolic Medicines
The retrospective on acetyl CoA carboxylase inhibitors, drug candidates that excited researchers a decade ago, illustrates the persistent scientific

prodchem
Aug 31, 2026
CF Industries is emerging as one of the clearest examples of strategic consistency in the 2026 low-carbon ammonia market. While companies such as Woodside are reconsidering major ammonia investments because demand, policy support and commercial returns have developed more slowly than expected, CF Industries has continued moving forward with its low-carbon ammonia strategy.
The strongest evidence came in August 2026, when CF Industries, JERA and Mitsui broke ground on Blue Point One, a 1.4-million-tonne-per-year low-carbon ammonia facility in Louisiana. The joint venture represents a $3.7 billion investment, with CF Industries holding a 40% stake, JERA 35% and Mitsui 25%. Production is expected to begin in 2029.
The importance of Blue Point One is that CF Industries has moved beyond announcements and feasibility studies. Permits were obtained during 2026 and construction began in August, creating a substantially different risk profile from projects that remain conceptual.
The project also benefits from an unusual combination of partners. CF contributes its established ammonia production and distribution capabilities, while JERA and Mitsui provide access to Japanese demand and international energy and trading markets. CF Industries has said the project has committed low-carbon ammonia volumes for applications including power generation and steel production.
That customer linkage is important because one of the biggest problems facing low-carbon ammonia developers is the gap between announced future demand and binding commercial demand.
CF Industries' consistency also comes from its decision to decarbonize existing ammonia production, rather than relying exclusively on new greenfield projects.
At its Donaldsonville complex, the company completed a carbon-capture dehydration and compression project in 2025. The system can enable permanent sequestration of up to approximately 2 million tonnes of CO₂ annually, giving CF the capacity to produce approximately 1.9 million tonnes of low-carbon ammonia per year at the complex. Similar decarbonization work is being pursued at Yazoo City.
This creates a two-track strategy:
Existing assets: progressively lower the carbon intensity of conventional ammonia production.
New capacity: develop dedicated low-carbon ammonia production for emerging markets.
That is strategically different from companies whose transition strategies depend almost entirely on a new technology or a new market appearing at the right time.
Another factor separating CF Industries from more speculative projects is that commercialization has already started.
CF reported that it began selling low-carbon upgraded products in 2026, with PepsiCo purchasing low-carbon UAN for use in its supply chain. The company had also previously completed sales of low-carbon ammonia from Donaldsonville to customers in Europe and Africa at premiums to conventional ammonia prices.
These transactions do not prove that the low-carbon ammonia market has reached maturity, but they provide evidence that customers are already willing to purchase products carrying a lower-carbon attribute.

Woodside's Beaumont review provides the clearest contrast. Woodside acquired the Texas ammonia facility for approximately $2.35 billion and initially positioned it as a major part of its new-energy strategy. In August 2026, however, the company placed the asset under comprehensive strategic review and abandoned its previous $5 billion new-energy investment target.
CF Industries is moving in the opposite direction.
Company | 2026 direction | Strategic signal |
|---|---|---|
CF Industries | Blue Point One construction begins | 1 — Commitment accelerating |
CF Industries | Existing-network CCS expansion | 2 — Decarbonization embedded in core assets |
Woodside | Beaumont strategic review | 3 — Transition portfolio reassessment |
Woodside | H2OK hydrogen retreat | 4 — Early-stage transition pullback |
The comparison is particularly useful because both companies are exposed to the same fundamental uncertainty: whether customers will pay enough for lower-carbon ammonia to justify the additional production and infrastructure costs.
CF Industries' business model gives it an advantage that many energy-transition developers do not have. Its core business is already ammonia. The company produces ammonia at large scale, sells it directly or converts it into products such as urea, UAN and ammonium nitrate, and operates an extensive distribution network.
That means low-carbon ammonia is being layered onto an existing commercial platform rather than created as an entirely new business.
The strategy also allows CF to serve two markets simultaneously. Traditional agricultural customers can purchase lower-carbon fertilizer products, while emerging applications in power generation, shipping and steel can create incremental demand for low-carbon ammonia.
CF's strategy is also closely connected to Japanese demand. JERA and Mitsui have been involved in the Blue Point project, while Japan's Ministry of Economy, Trade and Industry has established support mechanisms for low-carbon hydrogen and derivatives.
CF's regulatory filings note that JERA and Mitsui received Japanese certification under the country's Hydrogen Society Promotion Act, while a related Mitsui project received approval under Japan's hub-development support program. These developments provide an external demand signal for Blue Point rather than leaving the project dependent solely on an uncommitted future market.
CF's approach should not be interpreted as proof that low-carbon ammonia will inevitably become a major commodity market.
The economics remain sensitive to carbon prices, policy incentives, shipping infrastructure, production costs and the willingness of industrial customers to pay premiums. Analysts have also raised concerns about the cost and timing of ammonia demand in Japan's power sector.
CF therefore faces substantial execution risk. But its strategic consistency is notable because the company is managing that risk through existing production infrastructure, diversified end markets, international partners and actual customer commitments.
CF Industries currently ranks among the strongest examples of strategic consistency in low-carbon ammonia because it has continued committing capital even as parts of the broader sector have become more cautious.
The distinction is not simply that CF is optimistic about ammonia. It is that the company has integrated decarbonization into its existing ammonia franchise while simultaneously building a large new low-carbon facility. With Blue Point One now under construction and low-carbon products already reaching customers, CF's strategy has moved from a future-oriented transition narrative toward measurable commercial execution.
If Blue Point One reaches production in 2029 and the company continues securing premium markets for low-carbon ammonia and fertilizer products, CF could emerge as a benchmark for how incumbent commodity chemical producers can pursue decarbonization without abandoning their core business model.

Featured Product
Found this useful?
Continue Reading

The retrospective on acetyl CoA carboxylase inhibitors, drug candidates that excited researchers a decade ago, illustrates the persistent scientific

ACS Fall Meeting coverage examining acetyl CoA carboxylase inhibitors investigated for acne and liver disease treatment
This year's ACS Green Chemistry Challenge Awards specifically honored an innovation in cleaner pharmaceutical manufacturing